Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15510979rdf:typepubmed:Citationlld:pubmed
pubmed-article:15510979lifeskim:mentionsumls-concept:C0006142lld:lifeskim
pubmed-article:15510979lifeskim:mentionsumls-concept:C0013216lld:lifeskim
pubmed-article:15510979lifeskim:mentionsumls-concept:C1522449lld:lifeskim
pubmed-article:15510979lifeskim:mentionsumls-concept:C0677929lld:lifeskim
pubmed-article:15510979lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:15510979lifeskim:mentionsumls-concept:C1518527lld:lifeskim
pubmed-article:15510979lifeskim:mentionsumls-concept:C1522673lld:lifeskim
pubmed-article:15510979pubmed:issue4lld:pubmed
pubmed-article:15510979pubmed:dateCreated2004-10-29lld:pubmed
pubmed-article:15510979pubmed:abstractTextThe aim of this study was to investigate the efficacy of postoperative locoregional radiotherapy in patients with T1-T2 breast cancer and four or more positive axillary lymph nodes submitted to mastectomy or breast-conserving surgery followed by standard-dose or high-dose adjuvant chemotherapy. The incidence of locoregional relapses and the survival correlated with the number of positive nodes were recorded for each treatment arm.lld:pubmed
pubmed-article:15510979pubmed:languageenglld:pubmed
pubmed-article:15510979pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15510979pubmed:citationSubsetIMlld:pubmed
pubmed-article:15510979pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15510979pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15510979pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15510979pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15510979pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15510979pubmed:statusMEDLINElld:pubmed
pubmed-article:15510979pubmed:issn0300-8916lld:pubmed
pubmed-article:15510979pubmed:authorpubmed-author:LatiniPaoloPlld:pubmed
pubmed-article:15510979pubmed:authorpubmed-author:De...lld:pubmed
pubmed-article:15510979pubmed:authorpubmed-author:GoriStefaniaSlld:pubmed
pubmed-article:15510979pubmed:authorpubmed-author:AnselmoPaolaPlld:pubmed
pubmed-article:15510979pubmed:authorpubmed-author:AristeiCynthi...lld:pubmed
pubmed-article:15510979pubmed:authorpubmed-author:PerrucciElisa...lld:pubmed
pubmed-article:15510979pubmed:authorpubmed-author:MascioniFranc...lld:pubmed
pubmed-article:15510979pubmed:authorpubmed-author:FrattegianiAl...lld:pubmed
pubmed-article:15510979pubmed:issnTypePrintlld:pubmed
pubmed-article:15510979pubmed:volume90lld:pubmed
pubmed-article:15510979pubmed:ownerNLMlld:pubmed
pubmed-article:15510979pubmed:authorsCompleteYlld:pubmed
pubmed-article:15510979pubmed:pagination379-86lld:pubmed
pubmed-article:15510979pubmed:dateRevised2008-12-12lld:pubmed
pubmed-article:15510979pubmed:meshHeadingpubmed-meshheading:15510979...lld:pubmed
pubmed-article:15510979pubmed:meshHeadingpubmed-meshheading:15510979...lld:pubmed
pubmed-article:15510979pubmed:meshHeadingpubmed-meshheading:15510979...lld:pubmed
pubmed-article:15510979pubmed:meshHeadingpubmed-meshheading:15510979...lld:pubmed
pubmed-article:15510979pubmed:meshHeadingpubmed-meshheading:15510979...lld:pubmed
pubmed-article:15510979pubmed:meshHeadingpubmed-meshheading:15510979...lld:pubmed
pubmed-article:15510979pubmed:meshHeadingpubmed-meshheading:15510979...lld:pubmed
pubmed-article:15510979pubmed:meshHeadingpubmed-meshheading:15510979...lld:pubmed
pubmed-article:15510979pubmed:meshHeadingpubmed-meshheading:15510979...lld:pubmed
pubmed-article:15510979pubmed:meshHeadingpubmed-meshheading:15510979...lld:pubmed
pubmed-article:15510979pubmed:meshHeadingpubmed-meshheading:15510979...lld:pubmed
pubmed-article:15510979pubmed:meshHeadingpubmed-meshheading:15510979...lld:pubmed
pubmed-article:15510979pubmed:meshHeadingpubmed-meshheading:15510979...lld:pubmed
pubmed-article:15510979pubmed:meshHeadingpubmed-meshheading:15510979...lld:pubmed
pubmed-article:15510979pubmed:meshHeadingpubmed-meshheading:15510979...lld:pubmed
pubmed-article:15510979pubmed:meshHeadingpubmed-meshheading:15510979...lld:pubmed
pubmed-article:15510979pubmed:meshHeadingpubmed-meshheading:15510979...lld:pubmed
pubmed-article:15510979pubmed:meshHeadingpubmed-meshheading:15510979...lld:pubmed
pubmed-article:15510979pubmed:meshHeadingpubmed-meshheading:15510979...lld:pubmed
pubmed-article:15510979pubmed:meshHeadingpubmed-meshheading:15510979...lld:pubmed
pubmed-article:15510979pubmed:meshHeadingpubmed-meshheading:15510979...lld:pubmed
pubmed-article:15510979pubmed:meshHeadingpubmed-meshheading:15510979...lld:pubmed
pubmed-article:15510979pubmed:meshHeadingpubmed-meshheading:15510979...lld:pubmed
pubmed-article:15510979pubmed:meshHeadingpubmed-meshheading:15510979...lld:pubmed
pubmed-article:15510979pubmed:meshHeadingpubmed-meshheading:15510979...lld:pubmed
pubmed-article:15510979pubmed:meshHeadingpubmed-meshheading:15510979...lld:pubmed
pubmed-article:15510979pubmed:articleTitleT1-T2 breast cancer with four or more positive axillary lymph nodes: adjuvant locoregional radiotherapy with high-dose or standard-dose chemotherapy. Results of an observational study.lld:pubmed
pubmed-article:15510979pubmed:affiliationRadiotherapy Oncology, Policlinico Hospital and University of Perugia, Italy. teresa.perrucci@tiscalinet.itlld:pubmed
pubmed-article:15510979pubmed:publicationTypeJournal Articlelld:pubmed